Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge

被引:86
作者
Hohlfeld, JM
Ahlf, K
Enhorning, G
Balke, K
Erpenbeck, VJ
Petschallies, J
Hoymann, HG
Fabel, H
Krug, N
机构
[1] Hannover Med Sch, Dept Resp Med, D-30625 Hannover, Germany
[2] Fraunhofer Inst Toxicol & Aerosol Res, D-3000 Hannover, Germany
[3] SUNY Buffalo, Dept Obstet Gynecol, Buffalo, NY 14260 USA
关键词
D O I
10.1164/ajrccm.159.6.9806145
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Increased airway resistance in asthma may be partly due to poor function of pulmonary surfactant. This study investigated the inflammatory changes of bronchoalveolar lavage fluid (BALF) and the performance of BALF surfactant in healthy control subjects (n = 9) and patients with mild allergic asthma (n = 15) before and after segmental challenge. BALF was obtained for baseline values, and 24 h after challenge with saline solution in one lung segment and with allergen in another. Cell counts, phospholipid and protein concentrations, and ratios of small to large surfactant aggregates (SA/LA) were analyzed. Surface tension was determined with a pulsating bubble surfactometer, and the ability of the BALF surfactant to maintain airway patency was assessed with a capillary surfactometer. Baseline values of control subjects and asthmatics were not different. Challenge with saline and antigen raised total inflammatory cells in both control subjects and asthmatics. Allergen challenge of asthmatics, but not of healthy volunteers, significantly increased eosinophils, proteins, SA/LA, and surface tension at minimum bubble size, and diminished the time the capillary tube is open. In conclusion, allergen challenge in asthmatics induced surfactant dysfunction, probably mainly because of inhibiting proteins. During an asthma attack, narrow conducting airways may become blocked, which might contribute to an increased airway resistance.
引用
收藏
页码:1803 / 1809
页数:7
相关论文
共 35 条
  • [1] BARTLETT GR, 1959, J BIOL CHEM, V234, P466
  • [2] Conductive airway surfactant: Surface-tension function, biochemical composition, and possible alveolar origin
    Bernhard, W
    Haagsman, HP
    Tschernig, T
    Poets, CF
    Postle, AD
    vanEijk, ME
    vonderHardt, H
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (01) : 41 - 50
  • [3] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
  • [4] Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice
    Clark, JC
    Weaver, TE
    Iwamoto, HS
    Ikegami, M
    Jobe, AH
    Hull, WM
    Whitsett, JA
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (01) : 46 - 52
  • [5] BRONCHIAL REACTIVITY TO INHALED HISTAMINE - METHOD AND CLINICAL SURVEY
    COCKCROFT, DW
    KILLIAN, DN
    MELLON, JJA
    HARGREAVE, FE
    [J]. CLINICAL ALLERGY, 1977, 7 (03): : 235 - 243
  • [6] MUCOSAL INFLAMMATION IN ASTHMA
    DJUKANOVIC, R
    ROCHE, WR
    WILSON, JW
    BEASLEY, CRW
    TWENTYMAN, OP
    HOWARTH, PH
    HOLGATE, ST
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (02): : 434 - 457
  • [7] DISRUPTION OF PULMONARY SURFACTANTS ABILITY TO MAINTAIN OPENNESS OF A NARROW TUBE
    ENHORNING, G
    HOLM, BA
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1993, 74 (06) : 2922 - 2927
  • [8] PULSATING BUBBLE TECHNIQUE FOR EVALUATING PULMONARY SURFACTANT
    ENHORNING, G
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1977, 43 (02) : 198 - 203
  • [9] ENHORNING G, 1996, CAN RESPIR J, V3, P21, DOI [10.1155/1996/364751, DOI 10.1155/1996/364751]
  • [10] ARTIFICIAL PULMONARY SURFACTANT INHIBITED BY PROTEINS
    FUCHIMUKAI, T
    FUJIWARA, T
    TAKAHASHI, A
    ENHORNING, G
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1987, 62 (02) : 429 - 437